AtenololAntihypertensive AgentsHypertensionBlood PressureDiureticsHydrochlorothiazideAdrenergic beta-AntagonistsMethyldopaSodium Chloride Symporter InhibitorsAmlodipineCalcium Channel BlockersAngiotensin-Converting Enzyme InhibitorsPropanolaminesHydralazineDoxazosinThiazidesChlorthalidoneTrichlormethiazideBlood Pressure Monitoring, AmbulatoryDrug Therapy, CombinationNifedipineIndapamideBlood Pressure DeterminationBenzothiadiazinesLisinoprilRats, Inbred SHRHeart RateAngiotensin II Type 1 Receptor BlockersEnalaprilBendroflumethiazidePropranololDihydropyridinesMetoprololDouble-Blind MethodCaptoprilTetrazolesTreatment OutcomeAngiotensin Receptor AntagonistsGuanabenzClonidineLosartanHypertension, RenalPulseClinical Trials as TopicAdrenergic beta-1 Receptor AntagonistsPatient ComplianceBenzimidazolesRisk FactorsHypertrophy, Left VentricularTime FactorsAdrenergic alpha-AntagonistsSystolePerindoprilReninDrug PrescriptionsBisoprololLabetalolFollow-Up StudiesMinoxidilDihydralazineDrug UtilizationNordefrinNitrendipineRenin-Angiotensin SystemProspective StudiesPrazosinCardiovascular DiseasesDose-Response Relationship, DrugBiphenyl CompoundsRats, Inbred WKYMedication AdherencePhysician's Practice PatternsKidney Failure, ChronicPindololHypertension, RenovascularDrug InteractionsHypertension, MalignantHemodynamicsReserpineCeliprololRetrospective StudiesKidneyRandom AllocationRandomized Controlled Trials as TopicAcebutololPregnancy Complications, CardiovascularDrug CombinationsDrug CostsValineCohort StudiesDiastoleGuanfacineBenzoatesTriamtereneBetaxololPractice Guidelines as TopicOxprenololProteinuriaRenal Artery ObstructionNadolol